Skip to Main Content

Paper Details

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.
J Neurooncol
17
2017
Author NameAffiliation
Christopher M HovensThe Royal Melbourne Hospital, The University of Melbourne, Clinical Sciences Building
Andrew P MorokoffThe Royal Melbourne Hospital, The University of Melbourne, Clinical Sciences Building
Andrew P MorokoffThe Royal Melbourne Hospital
  • 1 - 3

Datasets

Release 1.2